These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Impact of depression on treatment effectiveness and gains maintenance in social phobia: a naturalistic study of cognitive behavior group therapy. Marom S; Gilboa-Schechtman E; Aderka IM; Weizman A; Hermesh H Depress Anxiety; 2009; 26(3):289-300. PubMed ID: 19170088 [TBL] [Abstract][Full Text] [Related]
32. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435 [TBL] [Abstract][Full Text] [Related]
33. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. Book SW; Thomas SE; Randall PK; Randall CL J Anxiety Disord; 2008; 22(2):310-8. PubMed ID: 17448631 [TBL] [Abstract][Full Text] [Related]
34. Phenelzine v imipramine in atypical depression. A preliminary report. Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621 [TBL] [Abstract][Full Text] [Related]
35. Phenelzine vs placebo in 50 patients with bulimia. Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482 [TBL] [Abstract][Full Text] [Related]
36. Dismantling cognitive-behavioral group therapy for social phobia. Hope DA; Heimberg RG; Bruch MA Behav Res Ther; 1995 Jul; 33(6):637-50. PubMed ID: 7654156 [TBL] [Abstract][Full Text] [Related]
37. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. Cummings CM; Caporino NE; Settipani CA; Read KL; Compton SN; March J; Sherrill J; Piacentini J; McCracken J; Walkup JT; Ginsburg G; Albano AM; Rynn M; Birmaher B; Sakolsky D; Gosch E; Keeton C; Kendall PC J Consult Clin Psychol; 2013 Oct; 81(5):859-64. PubMed ID: 23750468 [TBL] [Abstract][Full Text] [Related]
38. The link between social anxiety disorder, treatment outcome, and sleep difficulties among patients receiving cognitive behavioral group therapy. Kushnir J; Marom S; Mazar M; Sadeh A; Hermesh H Sleep Med; 2014 May; 15(5):515-21. PubMed ID: 24767722 [TBL] [Abstract][Full Text] [Related]
39. A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Tyrer P; Candy J; Kelly D Psychopharmacologia; 1973 Sep; 32(3):237-54. PubMed ID: 4586902 [No Abstract] [Full Text] [Related]
40. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Jenike MA; Baer L; Minichiello WE; Rauch SL; Buttolph ML Am J Psychiatry; 1997 Sep; 154(9):1261-4. PubMed ID: 9286186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]